Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Market Cap
$51.19M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$51.12M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$51.88M
Net Profit Margin
-5668.62%
TTM Avg
-3356.71%
3Y Avg
-1974.47%
5Y Avg
-1414.89%
Market Cap
$51.99M
Net Profit Margin
N/A
TTM Avg
-24.71%
3Y Avg
-12.36%
5Y Avg
-8.24%
Market Cap
$50.27M
Net Profit Margin
-11304.83%
TTM Avg
-9549.74%
3Y Avg
-8821.76%
5Y Avg
-6347.57%
Market Cap
$52.60M
Net Profit Margin
-59.97%
TTM Avg
-26.95%
3Y Avg
-5.27%
5Y Avg
-0.58%
Market Cap
$49.71M
Net Profit Margin
-91866.00%
TTM Avg
-196225.86%
3Y Avg
-104777.73%
5Y Avg
-90977.38%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| eXoZymes, Inc. (EXOZ) | $51.23M | 0.00% | 0.00% | 0.00% | N/A |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | 0.00% | 0.00% | 0.00% | 0.00% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| ImageneBio Inc (IMA)vs › | $51.88M | -5668.62% | -3356.71% | -1974.47% | -1414.89% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | N/A | -24.71% | -12.36% | -8.24% |
| biote Corp. (BTMD)vs › | $50.28M | 3.19% | 7.83% | 4.22% | 10.88% |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | -11304.83% | -9549.74% | -8821.76% | -6347.57% |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | -59.97% | -26.95% | -5.27% | -0.58% |
| INmune Bio, Inc. (INMB)vs › | $49.71M | -91866.00% | -196225.86% | -104777.73% | -90977.38% |
| Spectral AI, Inc. (MDAI)vs › | $52.83M | -69.27% | -45.15% | -54.32% | -40.58% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
